EBRO 2017

Gastric cancer adjuvant chemoradiation

EBRO 2017

D2 or not D2?

No survival benefit for D2 dissection

Operative mortality ≥ 10% in D2 patients But modern Japanese trials consistently show ~ 1% post-operative mortality for ≥ D2 surgery